21–22 of 22 posts
It's up to a regulatory body to make sure the manufacturers aren't exploiting their position in the market.
Earlier quoted context omitted.
I promise you the level of state-backed research for pharmaceuticals is much higher in the US than it is from "the countries that the author reckons are raising US drug prices." I would, however, be the first to tell you that throwing money at drug development is not a solution to good drug development, and may be counterproductive beyond a certain point.
Fair. I just had a look at the numbers. Is less clear when you drill down to individual countries and if you only look at the most virulent diseases, also with a lot of the funding, like the global fund for instance, many of the EC countries donate twice, once as part of their EC obligation, and again as a national donation, so you may miss a lot if you just look at EC funds. But you are definitely right overall, the…